Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Hermans

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Diabetes Care|December 5, 1998
Correct homeostasis model assessment (HOMA) evaluation uses the computer programJ C Levy, D R Matthews, M P Hermans
Diabetes & Metabolism|October 4, 2003
Comparative performance of serum cystatin-c versus serum creatinine in diabetic subjectsM Buysschaert, I Joudi, P Wallemacq, et al.
Acta Clinica Belgica|November 11, 1999
Insulin lispro (Humalog), a novel fast-acting insulin analogue: guidelines for its practical useF R Nobels, M P Hermans, I De Leeuw
Acta Clinica Belgica|January 24, 2013
Predictive factors associated with primary failure to exenatide and non goal attainment in patients with type 2 diabetesV Preumont, M P Hermans, M Bergman, et al.
Diabetes & Metabolism|October 29, 1997
Clinical aspects of diabetes secondary to idiopathic haemochromatosis in French-speaking BelgiumM Buysschaert, I Paris, P Selvais, et al.
The Biochemical Journal|August 15, 1988
Glucose-, calcium- and concentration-dependence of acetylcholine stimulation of insulin release and ionic fluxes in mouse isletsM C Garcia, M P Hermans, J C Henquin
Diabetes & Metabolism|April 15, 2018
Lipoprotein(a) levels are doubled in left-handed patients with diabetesM P Hermans, S A Ahn, M F Rousseau
Diabetes Care|June 1, 1994
Heart rate and blood pressure variations are unaffected in early microalbuminuric type I diabetic subjectsM P Hermans, P L Selvais, J M Ketelslegers
Diabetes & Metabolism|May 8, 2010
Six-month exenatide improves HOMA hyperbolic product in type 2 diabetic patients mostly by enhancing beta-cell function rather than insulin sensitivityV Preumont, M-P Hermans, S Brichard, et al.
Diabetes & Metabolism|June 22, 2013
What is the phenotype of patients with gastrointestinal intolerance to metformin?M P Hermans, S A Ahn, M F Rousseau
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Diabetes Care|December 5, 1998
Correct homeostasis model assessment (HOMA) evaluation uses the computer programJ C Levy, D R Matthews, M P Hermans
Diabetes & Metabolism|October 4, 2003
Comparative performance of serum cystatin-c versus serum creatinine in diabetic subjectsM Buysschaert, I Joudi, P Wallemacq, et al.
Acta Clinica Belgica|November 11, 1999
Insulin lispro (Humalog), a novel fast-acting insulin analogue: guidelines for its practical useF R Nobels, M P Hermans, I De Leeuw
Acta Clinica Belgica|January 24, 2013
Predictive factors associated with primary failure to exenatide and non goal attainment in patients with type 2 diabetesV Preumont, M P Hermans, M Bergman, et al.
Diabetes & Metabolism|October 29, 1997
Clinical aspects of diabetes secondary to idiopathic haemochromatosis in French-speaking BelgiumM Buysschaert, I Paris, P Selvais, et al.
The Biochemical Journal|August 15, 1988
Glucose-, calcium- and concentration-dependence of acetylcholine stimulation of insulin release and ionic fluxes in mouse isletsM C Garcia, M P Hermans, J C Henquin
Diabetes & Metabolism|April 15, 2018
Lipoprotein(a) levels are doubled in left-handed patients with diabetesM P Hermans, S A Ahn, M F Rousseau
Diabetes Care|June 1, 1994
Heart rate and blood pressure variations are unaffected in early microalbuminuric type I diabetic subjectsM P Hermans, P L Selvais, J M Ketelslegers
Diabetes & Metabolism|May 8, 2010
Six-month exenatide improves HOMA hyperbolic product in type 2 diabetic patients mostly by enhancing beta-cell function rather than insulin sensitivityV Preumont, M-P Hermans, S Brichard, et al.
Diabetes & Metabolism|June 22, 2013
What is the phenotype of patients with gastrointestinal intolerance to metformin?M P Hermans, S A Ahn, M F Rousseau
Pageof 8